| HANSA BIOPHARMA AB SK 1 |
| Schweden |
| Gesundheit |
| SE0002148817 / A0M65T |
| 24H (Frankfurt) |
| FRA:24H, ETR:24H, 24H:GR |
| - |
| https://hansabiopharma.co.. |
|
Hansa Biopharma AB (publ) is a commercial-stage biopharmaceutical company focused on pioneering the development and commercialization of innovative immunomodulatory treatments for patients with rare immunological conditions. Founded in 2007 and headq..
>Volltext.. |
| 307.8 Mio. EUR |
| 329.23 Mio. EUR |
| 20.83 Mio. EUR |
| - |
| -49.61 Mio. EUR |
| -0.6 EUR |
| 87.53 Mio. EUR |
| 65.72 Mio. EUR |
| -51.48 Mio. EUR |
| 1.71 |
| 37.48% |
| 30.48% |
| - |
| - |
| - |
| - |
| HANSA BIOPHARMA |
| 05.04.26 |
|